Correlation Between ATT and BridgeBio Pharma
Can any of the company-specific risk be diversified away by investing in both ATT and BridgeBio Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ATT and BridgeBio Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ATT Inc and BridgeBio Pharma, you can compare the effects of market volatilities on ATT and BridgeBio Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ATT with a short position of BridgeBio Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of ATT and BridgeBio Pharma.
Diversification Opportunities for ATT and BridgeBio Pharma
-0.46 | Correlation Coefficient |
Very good diversification
The 3 months correlation between ATT and BridgeBio is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding ATT Inc and BridgeBio Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BridgeBio Pharma and ATT is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ATT Inc are associated (or correlated) with BridgeBio Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BridgeBio Pharma has no effect on the direction of ATT i.e., ATT and BridgeBio Pharma go up and down completely randomly.
Pair Corralation between ATT and BridgeBio Pharma
Taking into account the 90-day investment horizon ATT is expected to generate 2.81 times less return on investment than BridgeBio Pharma. But when comparing it to its historical volatility, ATT Inc is 4.44 times less risky than BridgeBio Pharma. It trades about 0.21 of its potential returns per unit of risk. BridgeBio Pharma is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest 2,450 in BridgeBio Pharma on August 30, 2024 and sell it today you would earn a total of 299.00 from holding BridgeBio Pharma or generate 12.2% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
ATT Inc vs. BridgeBio Pharma
Performance |
Timeline |
ATT Inc |
BridgeBio Pharma |
ATT and BridgeBio Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with ATT and BridgeBio Pharma
The main advantage of trading using opposite ATT and BridgeBio Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ATT position performs unexpectedly, BridgeBio Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BridgeBio Pharma will offset losses from the drop in BridgeBio Pharma's long position.The idea behind ATT Inc and BridgeBio Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.BridgeBio Pharma vs. Blueprint Medicines Corp | BridgeBio Pharma vs. Amylyx Pharmaceuticals | BridgeBio Pharma vs. Day One Biopharmaceuticals | BridgeBio Pharma vs. Terns Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |